Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,738 papers from all fields of science
Search
Sign In
Create Free Account
MAP3K1 gene
Known as:
Mitogen-Activated Protein Kinase Kinase Kinase 1 Gene
, MAPKKK1
, MEK KINASE
Expand
This gene plays a role in mediating cellular responses to growth factors, metabolic stimuli and mitogens.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
MAP Kinase Kinase Kinase 1
MAP kinase kinase activity
MAP kinase kinase kinase activity
MAP3K1 protein, human
Expand
Narrower (1)
MAP3K1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Novel compound variants of the AR and MAP3K1 genes are related to the clinical heterogeneity of androgen insensitivity syndrome
Yiping Cheng
,
Yan Sun
,
+6 authors
Chao Xu
Bioscience Reports
2020
Corpus ID: 216557393
Abstract Androgen insensitivity syndrome (AIS; OMIM 300068) is the most frequent cause of 46, XY disorders of sex development…
Expand
2019
2019
Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
Z. Danková
,
P. Zubor
,
+10 authors
Z. Lasabová
Journal of Biotechnology
2019
Corpus ID: 125081658
2018
2018
Genetic Variation in MAP3K1 Associates with Ventilator‐Free Days in Acute Respiratory Distress Syndrome
E. Morrell
,
Shane D. O'Mahony
,
+8 authors
M. Wurfel
American Journal of Respiratory Cell and…
2018
Corpus ID: 207556777
&NA; Mitogen‐activated protein kinase kinase kinase 1 (MAP3K1) regulates numerous intracellular signaling pathways involved in…
Expand
Review
2018
Review
2018
Disorder of sex development 46,XY associated with mutations in the gene MAP3K1. The report of clinical cases
I. Kopylova
,
E. Kuznetsova
,
+5 authors
V. Peterkova
2018
Corpus ID: 54725155
The disorders of sex development (DSD) 46,XY may be caused by mutations in a number of genes involved in the gonadal…
Expand
2016
2016
Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Ayesha Mazhar
,
F. Jamil
,
+7 authors
M. Tariq
Molecular Medicine Reports
2016
Corpus ID: 32912399
Single nucleotide polymorphisms (SNPs) lead to genetic differences in breast cancer (BC) susceptibility among women from…
Expand
2015
2015
MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1.
Wen-qiao Zang
,
Xuan Yang
,
+5 authors
Guo-qiang Zhao
World Journal of Gastroenterology
2015
Corpus ID: 25552835
AIM To investigate the underlying molecular mechanisms of miR-451 to inhibit proliferation of esophageal carcinoma cell line…
Expand
2012
2012
Rapidly screening variants of uncertain significance in the MAP3K1 gene for phenotypic effects
J. Loke
,
H. Ostrer
Clinical Genetics
2012
Corpus ID: 14357394
Loke J, Ostrer H. Rapidly screening variants of uncertain significance in the MAP3K1 gene for phenotypic effects.
2012
2012
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations
M. A. de Bruin
,
A. Kwong
,
+11 authors
A. Kurian
Familial Cancer
2012
Corpus ID: 254514330
The prevalence and penetrance of BRCA1 and BRCA2 (BRCA1/2) mutations may differ between Asians and whites. We investigated BRCA1…
Expand
2010
2010
Familial brain arteriovenous malformation maps to 5p13-q14, 15q11-q13 or 18p11: linkage analysis with clipped fingernail DNA on high-density SNP array.
M. Oikawa
,
H. Kuniba
,
+4 authors
K. Yoshiura
European Journal of Medical Genetics
2010
Corpus ID: 15194649
2003
2003
Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line.
Celal Ulger
,
Gokce A. Toruner
,
+9 authors
J. Dermody
Cancer Genetics and Cytogenetics
2003
Corpus ID: 25946483
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE